Dr. Grossbard on the DYNAMO Study With Duvelisib in Follicular Lymphoma OncLive 0:57 4 years ago 291 Далее Скачать
Dr. Grossbard on the Role of Maintenance Rituximab in Follicular Lymphoma OncLive 1:17 4 years ago 544 Далее Скачать
Dr. Grossbard on the Utility of PI3K Inhibitors in Follicular Lymphoma OncLive 1:47 4 years ago 174 Далее Скачать
Dr. Grossbard on the Activity of Venetoclax in Follicular Lymphoma OncLive 0:50 4 years ago 295 Далее Скачать
Dr. Maddocks on Remaining Challenges in Follicular Lymphoma OncLive 1:08 4 years ago 81 Далее Скачать
Advances in the management of follicular lymphoma in the frontline and relapsed settings VJHemOnc – Video Journal of Hematology & HemOnc 3:37 9 years ago 159 Далее Скачать
Treatment After Progression in Follicular Lymphoma Targeted Oncology 6:50 4 years ago 442 Далее Скачать
Dr. Flinn on the Mechanism of Action and Toxicity Profile of Duvelisib (IPI-145) Targeted Oncology 1:50 9 years ago 327 Далее Скачать
Duvelisib, dual inhibitor of PI3K delta and PI3K gamma, for indolent non-Hodgkin lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 4:14 9 years ago 758 Далее Скачать
An Expert’s Perspective on Emerging Follicular Lymphoma Research Patient Empowerment Network 4:20 2 years ago 565 Далее Скачать
